(HealthDay)—For patients with rheumatoid arthritis (RA), one to three doses of tocilizumab may increase the risk of hepatitis B virus (HBV) reactivation, according to a study published online Feb. 3 in the International ...
Feb 13, 2017
0
1
(HealthDay)—Human pregnancy hormone chorionic gonadotropin (hCG) triggers immune suppression by attenuating the processing and release of Caspase-3-dependent interleukin (IL)-16, according to a study published online Jan. ...
Jan 26, 2017
0
0
Researchers have found that certain plant-derived products may help prevent and treat hepatitis B virus (HBV) infection. Proanthocyanidin (PAC) and its analogs, oolonghomobisflavanes, act by inhibiting viral entry into host ...
Jan 17, 2017
0
0
The technique that the hepatitis E virus—an emerging liver virus historically found in developing countries but now on the rise in Europe—uses to spread could present a weak spot scientists can exploit to treat the disease, ...
Jan 17, 2017
0
44
Patients with hepatitis C virus infection who received an antiviral drug around the time they underwent liver transplantation saw a high rate of sustained virologic response, according to a Northwestern Medicine phase II ...
Jan 10, 2017
0
2
(HealthDay)—For patients with advanced unresectable hepatocellular carcinoma, the effect of sorafenib on overall survival (OS) is dependent on patients' hepatitis status, according to a meta-analysis published online Jan. ...
Jan 9, 2017
0
0
(HealthDay)—For patients with hepatitis C virus (HCV) infection and biopsy-proven cirrhosis, sustained viral response (SVR) is associated with a reduction in critical events, both liver and non-liver related, according ...
Jan 4, 2017
0
0
(HealthDay)—For hepatitis C virus (HCV)-infected patients, diabetes mellitus (DM) is associated with increased risk of hepatocellular carcinoma (HCC) development and all-cause mortality, according to a study published online ...
Dec 19, 2016
0
0
There's new hope for patients with liver disease who are waiting for a donor liver to become available for transplantation.
Dec 14, 2016
0
2
Drugs against one type of hepatitis may activate another, sometimes with fatal consequences, Europe's medicines watchdog warned on Friday.
Dec 2, 2016
0
47
